Back to search

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice

Data up to Jan 2025

Published1999
Citations44
References15

Total Citations Per Year

Abstract

References (15)

Principles and Procedures of Statistics

1961 • 18,011 citations

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1980 • 8,534 citations

Progress in cancer research and therapy

1978 • 311 citations

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

1996 • 199 citations

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

1990 • 156 citations

Human prostatic adenocarcinoma: Some characteristics of a serially transplantable line in nude mice (PC 82)

1980 • 144 citations

Receptors for luteinizing hormone‐releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia

1989 • 124 citations

Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix.

1996 • 96 citations

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin.

1996 • 92 citations

Growth Inhibition of Human Ovarian Cancers by Cytotoxic Analogues of Luteinizing Hormone-Releasing Hormone

1997 • 75 citations

Screening for prostate cancer—Necessity or nonsense?

1993 • 56 citations

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone

1997 • 55 citations

Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6.

1989 • 53 citations

Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer

1992 • 36 citations

Hormonal Therapy of Prostatic Carcinoma

1990 • 26 citations

Cited By (0)

No citing papers found in database

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the… (1999) – The Prostate | Metascience Observatory Explorer